Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Starting soon

Conditions studied: Recurrent Ovarian Cancer

In brief

Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to support their widespread adoption. By actively participating in recurrent ovarian cancer observational study serves pivotal role in expanding the boundaries of medical knowledge and advancing the quality of care provided to those enduring the same condition.

Key facts

Study ID

NCT06070285

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-10-01

Expected to finish

2026-10-01

Last updated by the study team

2023-10-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥ 18 years old
• Able to comprehend the investigational nature of the protocol and provide informed consent
• Diagnosis of recurrent ovarian cancer

You may not qualify if…

• No diagnosis of recurrent ovarian cancer confirmed
• Inability to perform regular electronic reporting
• Patient does not understand, sign, and return consent form

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.